XML 41 R18.htm IDEA: XBRL DOCUMENT v3.20.1
Note 12 - Income Taxes
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
12.
INCOME TAXES
 
 
A reconciliation of the provision of income taxes to the statutory federal income tax rate is as follows:
 
   
Year
   
Year
 
   
December 31, 2019
   
December 31, 2018
 
                 
Income Before Provision for Income Taxes
  $
9,419,490
    $
5,281,730
 
Statutory rate
   
21
%
   
21
%
Tax at statutory rate
   
1,978,092
     
1,109,163
 
State taxes, net of federal benefit
   
551,179
     
79,165
 
Permanent differences
   
23,889
     
196,142
 
Return to Provision Adjustments and Other
   
(113,533
)
   
283,550
 
Provision for income taxes
  $
2,439,627
    $
1,668,020
 
 
Deferred tax assets (liabilities) consist of the following: 
 
   
December 31,
2019
   
December 31,
2018
 
                 
Inventories
  $
164,768
    $
145,844
 
Bad debts
   
4,659
     
8,773
 
Accrued liabilities
   
279,508
     
281,475
 
Prepaid expense
   
(116,524
)
   
(95,371
)
Depreciation and amortization
   
(2,798,040
)
   
(2,928,232
)
Research and development and other credit carryforwards
   
556,387
     
1,266,043
 
Right of use lease accounting
   
(19,600
)    
-
 
Directors stock option plan
   
163,427
     
62,134
 
Total deferred tax liability
   
(1,765,415
)
   
(1,259,334
)
Valuation allowance
   
(47,319
)
   
(47,319
)
Reserve for uncertain tax positions
   
(395,000
)
   
(395,000
)
Total reserves & allowances
   
(442,319
)
   
(442,319
)
Net deferred tax liability, net of reserves
  $
(2,207,734
)
  $
(1,701,653
)
 
Valuation Allowance

The Company has a valuation allowance for deferred tax assets based upon certain credits that
may
not
be fully utilized in the future. The Company believes the valuation allowance of
$47
thousand at
December 31, 2019
and
2018,
respectively, is adequate.
 
Reserve for Uncertain Tax Positions

The Company has a reserve of unrecognized tax benefits related to exposures in accordance with ASC
740.
The Company believes the valuation allowance of
$0.4
million at
December 31, 2019
and
2018,
respectively, is adequate. Due to the uncertainties involved with this significant estimate, it is reasonably possible that the Company’s estimate
may
change in the near term.
 
Tax Credits
and Net Operating losses
:
At
December 31, 2019,
the Company has state net operating losses (NOLs) and research and development (R&D) and other credit carryforwards for tax purposes which expire as follows: 
 
Tax Year
Expires
 
State
NOLs
   
R& D & Other Credits
 
2020
   
-
     
3,000
 
2021
   
-
     
3,000
 
2022
   
-
     
3,000
 
2023
   
-
     
3,000
 
2024
   
-
     
3,000
 
2025
   
-
     
3,000
 
2026
   
-
     
72,216
 
2027
   
-
     
152,732
 
2028
   
-
     
68,676
 
2029
   
191,519
     
31,081
 
2030
   
414,231
     
44,712
 
2031
   
641,229
     
59,085
 
2032
   
-
     
71,062
 
2033
   
532,837
     
73,198
 
2034
   
285,607
     
76,429
 
2035
   
-
     
73,315
 
2036 and beyond
   
-
     
-
 
    $
2,065,423
    $
740,506